CollPlant Biotechnologies (NASDAQ:CLGN) Given New $12.00 Price Target at D. Boral Capital
CollPlant Biotechnologies (NASDAQ:CLGN – Free Report) had its target price trimmed by D. Boral Capital from $14.00 to $12.00 in a research report report published on Wednesday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. CollPlant Biotechnologies Stock Up 76.2% CLGN opened at $3.40 on Wednesday. The business has a 50 […]
CollPlant Biotechnologies (NASDAQ:CLGN – Free Report) had its target price trimmed by D. Boral Capital from $14.00 to $12.00 in a research report report published on Wednesday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. CollPlant Biotechnologies Stock Up 76.2% CLGN opened at $3.40 on Wednesday. The business has a 50 […]
